Tumor Board
The December 10, 2019 BOTSOGO Tumor Board has been postponed due to faculty scheduling conflicts. The case of “Elevated CA 15-3 tumor marker in a young breast cancer patient” will be discussed in January 2020 (date to be announced). Please check back for details.
Topic: “Elevated CA 15-3 tumor marker in a young breast cancer patient.”
MGH location: Cox 6 Conference Room; Francistown location: Nyangabgwe Referral Hospital, Conference Room, Admin Block 1st Floor; Gaborone location: Botswana-Harvard AIDS Institute, PMH grounds, Conference Room, Ground Floor.
All are welcome.
10 am (Eastern Time), Boston, MA, Massachusetts General Hospital, Cox 6 Conference Room.
5 pm (Central Africa Time), Francistown, Botswana, Nyangabgwe Referral Hospital, Conference Room, Admin Block 1st Floor. Light dinner and refreshments to follow.
5 pm (Central Africa Time), Gaborone, Botswana, Botswana-Harvard AIDS Institute, PMH grounds, Conference Room, Ground Floor. Light dinner and refreshments to follow
For questions, or to be added to our tumor board mailing list, please contact BOTSOGO@partners.org.
About the Tumor Boards:
We have established the first sustainable multidisciplinary tumor board in Botswana, which connects the Botswana oncology community with MGH/Harvard-based disease site experts. Utilizing an internet-based platform, we have fostered relationships not only between physicians in Botswana and at MGH/Harvard, but also among care providers within Botswana. In addition to providing a venue for education and constructive peer review, the conference provides a regular forum to discuss relevant health systems issues and for multidisciplinary discourse. The tumor board has covered a wide range of cases and topics selected by care providers of patients in Botswana. Case presentations by the treating physicians in Botswana are followed by an open discussion of challenging diagnostic, treatment, or heath system issues that impact the care of the patient.
Continuing Education Credits
BOTSOGO Tumour Board Attendance and Evaluation Survey for Tumor Board attendees
The BOTSOGO Tumor Board is accredited by Harvard Medical School’s (HMS) Offices of Global and Continuing Education. Tumor Board participants wishing to receive CME credit should fill out this survey. Completion of the survey is required to receive CME credit for each Tumor Board session you attend. Education certificates are distributed at the end of the academic year.